Tech Company Financing Transactions

BioClin Therapeutics Funding Round

BioClin Therapeutics, operating out of San Leandro, secured $30 million in investment from Sofinnova Ventures, Ysios Capital and Healthcap Venture Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1040 Davis St. 202
San Leandro, CA 94577
USA

Phone

(925) 413-6140

Website

www.bioclintherapeutics.com

Email Address

[email protected]

Overview

Our strategy is to develop biologics for medical conditions where there has been no approved or satisfactory therapy. Our lead product, B-701, is a human antibody targeting FGFR3 (fibroblast growth factor receptor 3) being developed as a treatment for metastatic bladder cancer and achondroplasia (dwarfism).

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Stephen Lau

        

Chief Medical Officer

Steve Abella

        

Chief Operating Officer

Graeme Currie

        

VP - Finance

Guy Shields

        

VP - Manufacturing

Eric Emery

        

VP - Operations

Isagani Cornelio

        

Browse more venture capital transactions:

Prev: 3/23/2017: Mythic venture capital transaction
Next: 3/23/2017: HotelTonight venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on all VC transactions involving tech companies. VC transactions reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary